HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laura Borsi Selected Research

Interleukin-12 (IL 12)

6/2003Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laura Borsi Research Topics

Disease

18Neoplasms (Cancer)
08/2013 - 03/2002
6Carcinoma (Carcinomatosis)
04/2010 - 07/2004
3Necrosis
08/2013 - 07/2010
3Squamous Cell Carcinoma of Head and Neck
01/2007 - 08/2005
3Adenocarcinoma
01/2005 - 01/2003
2Fibrosarcoma
08/2013 - 04/2006
1Osteosarcoma (Osteogenic Sarcoma)
08/2013
1Arthritis (Polyarthritis)
11/2011
1Neoplasm Metastasis (Metastasis)
09/2011
1Esophageal Neoplasms (Esophageal Cancer)
02/2011
1Neuroblastoma
07/2010
1Renal Cell Carcinoma (Grawitz Tumor)
04/2010
1Cystitis
10/2009
1Fibrosis (Cirrhosis)
07/2008
1Myocarditis (Carditis)
07/2008
1Hematologic Neoplasms (Hematological Malignancy)
06/2008
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2005
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
07/2004
1Prostatic Intraepithelial Neoplasia
07/2004
1Colorectal Neoplasms (Colorectal Cancer)
01/2003
1Teratocarcinoma
12/2002
1Astrocytoma (Pilocytic Astrocytoma)
11/2002
1Vascular Tissue Neoplasms
03/2002

Drug/Important Bio-Agent (IBA)

11Fibronectins (Fibronectin)IBA
08/2013 - 03/2002
11Proteins (Proteins, Gene)FDA Link
08/2013 - 03/2002
7TenascinIBA
10/2009 - 01/2003
6Immunoglobulin FragmentsIBA
08/2013 - 12/2002
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2010 - 06/2003
4Protein Isoforms (Isoforms)IBA
02/2011 - 03/2002
3Melphalan (Alkeran)FDA LinkGeneric
08/2013 - 04/2006
3AntibodiesIBA
04/2010 - 11/2002
3Monoclonal AntibodiesIBA
06/2008 - 12/2002
3KalininIBA
01/2007 - 08/2005
3CytokinesIBA
01/2005 - 03/2002
2CollagenIBA
11/2011 - 01/2003
2Extracellular Matrix ProteinsIBA
09/2011 - 01/2003
2ErbB Receptors (EGF Receptor)IBA
02/2011 - 08/2005
2Therapeutic UsesIBA
07/2010 - 06/2003
2Interleukin-2 (IL2)IBA
07/2010 - 03/2002
2Messenger RNA (mRNA)IBA
08/2006 - 07/2004
1GemcitabineFDA Link
08/2013
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
09/2011
1PeriostinIBA
09/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2011
1vandetanib (ZD6474)IBA
02/2011
1Angiogenesis InhibitorsIBA
02/2011
1Immunoconjugates (Immunoconjugate)IBA
02/2011
1Tyrosine Kinase InhibitorsIBA
02/2011
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2011
1RNA Precursors (Precursor, mRNA)IBA
02/2010
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
07/2008
1Hydroxyproline (4 Hydroxyproline)IBA
07/2008
1platelet-derived growth factor AIBA
07/2008
1Phosphotransferases (Kinase)IBA
07/2008
1Platelet-Derived Growth FactorIBA
07/2008
1Imatinib Mesylate (Gleevec)FDA Link
07/2008
1AntigensIBA
06/2008
1F8 monoclonal antibodyIBA
06/2008
1Amino AcidsFDA Link
06/2008
1p38 Mitogen-Activated Protein KinasesIBA
08/2005
1Interleukin-6 (Interleukin 6)IBA
01/2005
1Collagen Type V (Type V Collagen)IBA
01/2005
1RNA (Ribonucleic Acid)IBA
07/2004
1Phenobarbital (Luminal)FDA Link
07/2004
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2004
1Interleukin-12 (IL 12)IBA
06/2003
1LigandsIBA
12/2002
1Calmodulin (Calcium-Dependent Activator Protein)IBA
12/2002
1Immunoglobulin G (IgG)IBA
11/2002
1Factor VIII (Coagulation Factor VIII)IBA
11/2002
1Staphylococcal Protein A (Protein A)IBA
03/2002
1Interferon-gamma (Interferon, gamma)IBA
03/2002

Therapy/Procedure

8Therapeutics
08/2013 - 12/2002
2Lasers (Laser)
01/2007 - 07/2006
1Intravenous Injections
06/2008
1Aftercare (After-Treatment)
12/2007